Multicentre Randomised Controlled Trial Confirms the Significant Benefits of Phagenyx® Treatment for Tracheostomised Stroke Patients With Dysphagia

MANCHESTER, England, September 4, 2018 /PRNewswire/ -- Phagenesis Ltd, a pioneering leader in the treatment of dysphagia, is pleased to announce today the publication of its most recent randomised controlled trial (PHAST-TRAC) in the journal Lancet Neurology. Reinhard Krickl, CEO...

from PR Newswire: //https://ift.tt/2NeDYKw